SMARTdrugs: Supramolecular Agents as Radiotheranostic Drugs
Read more
RuNNINg: Gut-targeted RNA-based nanoparticles for fibrostenotic Crohn's Disease
THERAGET: Dendronized nanoparticles designed for targeted multimodal image guided therapy
NAVIGATE: Development and optimization of a new series of preclinical imaging systems for the in-vivo characterization of new drugs and biomolecules
BreastCaRANKL: Development of an innovative mouse model of RANKL-induced breast cancer and integration of cutting-edge technologies for the establishment of a preclinical platform for drug evaluation
PEPSA-MATE: Assembling nature's building blocks in new ways for novel bioproducts
UNAT: Ultra small Nanoparticles for Advanced Theranostics
B2B: Modeling spontaneous breast cancer metastasis to the bone with a first-of-its-kind 3D device that recapitulates physiological tissue-level complexity.
Polythea: Design and photo-optimization of photosensitizers for human health and food security application.
Cupido: development of inhalable nanoparticles that can deliver a therapy directly to the diseased heart.
VIVOIMAG: multimodal imaging of the in vivo fate of bone transplants
EYES: our preclinical benchtop scanners for in vivo imaging of PET, SPECT, Alpha Emitting radiopharmaceuticals & Optical Dyes
Interpretability of Deep Neural Networks for Radiomics
Development of a safe, scalable and highly sensitive multimodal cell nano-imaging agent ready for monitoring, longitudinal and quantitative discrimination of living stem cells in humans
Personalized Optimization of Prognostic and therapeutic protocols with Lu-177 for MNETs, with the development of advanced computational tools and a portable detection sYstEm.
PediDose: A pediatric simulated dosimetry platform for clinical use
